Development of estrogen receptor b selective receptor agonists to treat neuropath

Ended Cooperative Agreement Awarded Last action

Award ID
U44NS070336
Recipient
Awarding agency
Obligated
$600,000

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Originally
Place of performance
San Diego, CA 92121, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$866,941
Amendment $866,941
Amendment $300,000
Original award $300,000

Quick answers

Who received award U44NS070336?

U44NS070336 was awarded to Acadia Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on May 15, 2011.

How much is award U44NS070336 worth?

$600,000 has been obligated on U44NS070336.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award